Recombinant Mouse Interferon alpha/beta receptor 1 (Ifnar1), partial

Code CSB-YP011046MO1
Size Pls inquire
Source Yeast
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP011046MO1
Size Pls inquire
Source E.coli
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP011046MO1-B
Size Pls inquire
Source E.coli
Conjugate Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-BP011046MO1
Size Pls inquire
Source Baculovirus
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-MP011046MO1
Size Pls inquire
Source Mammalian cell
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
>85% (SDS-PAGE)
Target Names
Ifnar1
Uniprot No.
Alternative Names
Ifnar1; Ifar; Ifnar; Interferon alpha/beta receptor 1; IFN-R-1; IFN-alpha/beta receptor 1; Type I interferon receptor 1
Species
Mus musculus (Mouse)
Protein Length
Partial
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Form
Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer before Lyophilization
Tris/PBS-based buffer, 6% Trehalose, pH 8.0
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet
Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Component of the receptor for type I interferons, including interferons alpha, IFNB1 and IFNW1. Functions in general as heterodimer with IFNAR2. Type I interferon binding activates the JAK-STAT signaling cascade, and triggers tyrosine phosphorylation of a number of proteins including JAKs, TYK2, STAT proteins and the IFNR alpha- and beta-subunits themselves. Can form an active IFNB1 receptor by itself and activate a signaling cascade that does not involve activation of the JAK-STAT pathway. Contributes to modulate the innate immune response to bacterial lipopolysaccharide.
Gene References into Functions
  1. Only type-I interferon restricts viral replication of attenuated Measles virus (MV) Schwarz strain in mice, independently of the presence of hCD46 receptor. PMID: 30199752
  2. A key role of the IL7 and Interferon type I receptor axis in the regulation of intratumoral t-cell functions and in the development of primary breast tumor growth and metastasis. PMID: 29070614
  3. Data, including data from studies in knockout and double-knockout mice, suggest complex and sex-specific roles of Ifnar1 and Ifnar2 in type 1 diabetes (T1D); female NOD mice develop T1D in absence of both Ifnar1 and Ifnar2, whereas male mice do not. PMID: 30084830
  4. we uncovered that IFNAR1 expression in stromal benign cells functions to protect against progression of leukemia. PMID: 28503979
  5. Concurrent ablation of Ifnar1 led to a modest attenuation of the CK1alpha-null phenotype indicating that, although other CK1alpha targets are likely to be important, IFNAR1 downregulation can contribute to the maintenance of the HSCs function. PMID: 28678581
  6. Central nervous system signaling through IFNAR1 is a factor that is critical to neural injury after stroke. PMID: 28647375
  7. a deleterious role for the type-1 IFNs as key modulators of the early neuroinflammatory response and therefore the neuronal cell death in Parkinson's disease PMID: 27404846
  8. results clearly demonstrate that: (i) MHV-68, MHV-72 and MHV-4556 differentially interact with intracellular signaling and dysregulate IFN signal transduction; (ii) MHV-68, MHV-72 and MHV-4556 degrade type I IFN receptor in very early stages of infection (2-4hpi), but not type III IFN receptor PMID: 27152708
  9. Results show that removal of type-1 IFN signalling in the APPSWE/PS1DeltaE9 mouse model of AD confers a predominantly anti-inflammatory glial response and protects from cognitive decline. However this phenotype does not correlate with alterations in amyloid deposition and only a modest reduction in Abeta monomer levels. PMID: 27400725
  10. transfusion-induced differentiation of IFNAR1(-/-) B cells into germinal center B cells and plasma cells was significantly reduced, compared to WT B cells. This study demonstrates that B cells require signaling from IFN-alpha/beta to produce alloantibodies to the human KEL glycoprotein in mice. PMID: 28836263
  11. study provides evidence of STING activation in T cells, in which STING agonists not only provoke type I IFN production and IFN-stimulated gene expression, mirroring the response of innate cells, but are also capable of activating cell stress and death pathways. PMID: 28615418
  12. These data suggest that plasmacytoid dendritic cells producing IFN-alpha and IL-33 play a pivotal role in the chronic fibro-inflammatory responses underlying murine autoimmune pancreatitis and human IgG4-related autoimmune pancreatitis. PMID: 28373582
  13. type I interferons, besides their known antiviral properties, can initiate the recruitment and activation of leukocytes via induction of chemokine expression including CCL2. PMID: 26992431
  14. these studies demonstrate an important role for type I IFN in skin fibrosis, and they provide a rationale for IFNAR1 inhibition in scleroderma PMID: 27226090
  15. These results identify a key interface created by IFNAR1 residues Tyr(240) and Tyr(274) interacting with IFN-beta residues Phe(63), Leu(64), Glu(77), Thr(78), Val(81), and Arg(82) that underlie IFN-beta-IFNAR1-mediated signaling and biological processes. PMID: 28289093
  16. IFNAR1-deficiency accelerated humoral immune responses and parasite control by boosting ICOS-signalling in two non-lethal murine models of malaria PMID: 27812214
  17. reduced type I interferon production in obesity is caused by SOCS3 overexpression as well as tolerance induced by leptin PMID: 27704310
  18. These identify A129 mice as being highly susceptible to ZIKV and thus A129 mice represent a suitable, and urgently required, small animal model for the testing of vaccines and antivirals. PMID: 27149521
  19. Downregulation of IFNAR1 promotes melanoma development and progression. IFNAR1 mutation, which is partially resistant to downregulation, delays melanoma development. PMID: 27052162
  20. Data demonstrate that Type-1 interferons signaling is a critical pathway in the progression of neuroinflammation and presents a viable therapeutic target for the treatment of traumatic brain injury. PMID: 27022620
  21. The study provides evidence for the importance of brain endothelial and epithelial cells in the communication between the Central Nervous System and the immune system, and demonstrates tissue specific IFNAR1 engagement during sickness behavior. PMID: 27096319
  22. Data show that both NF-kappaB (NF-kappaB) and tonic interferon signals are involved in the final maturation of thymocytes into naive T cells. PMID: 27043411
  23. role in megakaryo- and thrombopoiesis PMID: 26134179
  24. ablation of Ifnar1 partially protected mice from caerulein-induced pancreatitis, as demonstrated by reduced tissue damage and macrophage recruitment. PMID: 26618925
  25. IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development PMID: 26232452
  26. IFN-I receptor 1 deficient mice (IFNAR1(-/-)) displayed significantly attenuated poly I:C-induced hypothermia, hypoactivity and weight loss compared to WT C57BL/6 mice. PMID: 25900439
  27. Data suggest MyD88 (myeloid differentiation primary response protein) is redundant for Ifnar1/IFN-I (interferon type I) responses and overall defense/innate immunity against systemic mouse Cytomegalovirus infection; this is consistent with human data. PMID: 25954804
  28. IFNAR1 signaling in microglia is essential for ischemic preconditioning in white matter. PMID: 26609155
  29. Lack of IFNB or IFNAR was associated with reduced neurogenesis in the hippocampus; dentate gyrus PMID: 26451483
  30. Taken together, our studies provide novel insights on how type I IFN receptor signaling regulates NK cell development and functions PMID: 25333658
  31. IFN-alpha/beta is able to drive the formation of a Stat2 and IRF-9 complex that drives the expression of a subset of IFN-stimulated genes, but with substantially delayed kinetics. PMID: 26019270
  32. our findings describe a novel role for IFN during metastasis development and suggest that new treatment strategies should be considered for prevention of metastasis formation in patients. PMID: 25604426
  33. TNFR1- and IFNAR1-deficient mice showed partial protection toward Aldara-induced inflammation compared with control groups. Double knockout mice lacking both receptors showed superior protection to Aldara in comparison with the single knockout mice. PMID: 25911755
  34. Impaired clearance of the high pathogenicity H1N1 influenza A virus prolonged IFN expression, leading to CCR2+ inflammatory monocytes amplifying their own recruitment via an interferon-alpha/beta receptor 1 (IFNAR1)-triggered chemokine loop. PMID: 25407417
  35. IFN-alpha/beta receptor signaling promotes regulatory T cell development and function under stress conditions. PMID: 25795758
  36. enhances cytotoxic activities of NK and CD8+ T cells but suppresses IFN-gamma production by these cells via the induction of IL-10 PMID: 24435166
  37. IRF7 suppresses antiparasitic immunity in the spleen, while IFNAR1-mediated, but IRF7-independent, signaling contributes to pathology in the brain during experimental blood-stage malaria. PMID: 25319247
  38. The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting interferon-alpha and interferon-beta expression. PMID: 25297874
  39. IFNAR1 joins several other genetic risk factors of Inflammatory Bowel Diseases whose products profoundly affect the intestinal microbiota and or Paneth cell function. PMID: 24555997
  40. Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis. PMID: 24743949
  41. Trigger IFNAR1 ubiquitination for limiting the inflammation-induced tissue damage can be purposely mimicked for therapeutic benefits. PMID: 24480543
  42. Collectively, persistent HBV replication IFNAR(-/-) mouse model that we established is a useful and convenient tool to detect the function of the type I interferon and IFNAR in HBV infection and anti-HBV treatments. PMID: 23771666
  43. TLR7-deficient and IFNAR1-deficient mice were more susceptible to liver fibrosis than wild type mice, indicating that TLR7-type I IFN signaling exerts a protective effect against liver fibrosis. PMID: 24375615
  44. Interferon-alpha but not MDA5/TLR3 activation of dendritic cells is required for maturation and metabolic shift to glycolysis after poly IC stimulation. PMID: 24409099
  45. Type I IFN receptor signaling acts as a central driver of early proinflammatory responses in the lung. PMID: 24648449
  46. Mice lacking the IFN-alpha/beta receptor succumbed to the infection, with vesicular stomatitis virus spreading from the olfactory bulb throughout the brain. PMID: 24429359
  47. IFNAR-/- mice were highly susceptible to severe fever with thrombocytopenia syndrome virus infection, and all mice died within 3 to 4 days after inoculation. PMID: 24257618
  48. This study provided evidence for the production of IFNbeta from glia and using mice deficient in the type I IFN receptor alpha 1 (IFNAR1), demonstrate that its subsequent activation is likely to underlie the TLR3-mediated modulation of hippocampal excitability. PMID: 23554175
  49. Type I interferon signaling and responses limit HIV-1 infection and pathogenesis in brain. PMID: 24335529
  50. Data suggest Ifnar1 plays critical role in regulation of innate immunity; Oasl1 knockout mice mount better virus-specific CD8-positive T-cell response to lymphocytic choriomeningitis virus and this response is blocked if Ifnar1 signaling is blocked. PMID: 23874199

Show More

Hide All

Subcellular Location
Cell membrane; Single-pass type I membrane protein. Late endosome. Lysosome.
Protein Families
Type II cytokine receptor family
Database Links

KEGG: mmu:15975

STRING: 10090.ENSMUSP00000023689

UniGene: Mm.502

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X